Why is bioAffinity Technologies, Inc. ?
- The company has reported losses. Due to this company has reported negative ROE
- NET SALES(Q) At USD 1.35 MM has Fallen at -27.09%
- OPERATING CASH FLOW(Y) Lowest at USD -10.92 MM
- ROCE(HY) Lowest at -622.65%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -87.79%, its profits have fallen by -22.8%
- Along with generating -87.79% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is bioAffinity Technologies, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at USD -6.77 MM
Fallen by -29.34% (YoY
At USD 1.35 MM has Fallen at -27.09%
Lowest at USD -10.92 MM
Lowest at -622.65%
Lowest at 72.9 times
Lowest at 6.86 times
Lowest at USD -3.5 MM
Lowest at -259.15 %
Lowest at USD -3.63 MM
Lowest at USD -3.63 MM
Here's what is working for bioAffinity Technologies, Inc.
Raw Material Cost as a percentage of Sales
Here's what is not working for bioAffinity Technologies, Inc.
Net Sales (USD MM)
Operating Cash Flows (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
Inventory Turnover Ratio
Debtors Turnover Ratio






